This D.C. biotech is raising millions to catch heart attacks before they strike — with a simple blood test

<span>True Bearing Diagnostics Inc. is working to commercialize an early-detection test for coronary artery disease, a possible game-changer for the health care industry.</span>

By   – Staff Reporter, Washington Business Journal

 Updated 

True Bearing Diagnostics Inc. is working to commercialize an early-detection test for coronary artery disease, a possible game-changer for the health care industry.

True Bearing Diagnostics CEO Tisha Jepson co-founded the D.C. biotech in 2015.

Enlarge

True Bearing Diagnostics CEO Tisha Jepson co-founded the D.C. biotech in 2015.

COURTESY TISHA JEPSON

Source: www.bizjournals.com